RE:RE:RE:RE:RE:RE:RE:RE:TH is dead money That's the bottom line in all this, you don't know, you think. It's not a matter of knowing or a matter of real facts, it's a matter of thinking about the potential, hence of opinion.
I think they are undervaluated based on what I think will happen, but it's only my opinion, or my guess, maybe an educated guess at best, but still a guess. The thing is that it is also the position the management is in. Clinical trials exist for a reason, to prove that drug candidates are safe and efficacious. So if I am CEO of a biopharma company I can express my confidence in the outcome of trials, but there is a fine line between expressing confidence and making believe it is a sure thing. Every time I heard Levesque he came across as confident in the prospects of NASH and oncology, not only confident, but enthusiastic, but he concluded by saying that what they needed to do first was to inject patients in clinical trials.
ANALIAS00 wrote:
- If you know that SP is undervaluated knowing time will prove it, you must not wait and act asap. Be hungry.